[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bayer A G Ord (BAYZF)

Bayer A G Ord (BAYZF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 20.57
  • Price/Book 5.23
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.0400 +49.85%
on 06/03/26
61.3800 -2.25%
on 07/02/26
+21.0600 (+54.08%)
since 06/02/26
3-Month
38.9400 +54.08%
on 06/02/26
61.3800 -2.25%
on 07/02/26
+14.2500 (+31.15%)
since 04/02/26
52-Week
29.1600 +105.76%
on 08/06/25
61.3800 -2.25%
on 07/02/26
+28.8000 (+92.31%)
since 07/02/25

Most Recent Stories

More News
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart

One A Day®, the multivitamin and supplement brand from Bayer, has partnered with country superstar and five time Entertainer of the Year Luke Bryan to launch a limited edition multivitamin bottle featuring...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon

Advances key component of Crop Science division’s Five-Year Framework strategy Reinforces commitment to delivering trusted Roundup ® brands and glyphosate...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Bayer and Iambic Collaborate to Advance Drug Discovery with AI

Collaboration focuses on small molecule discovery Bayer to leverage Iambic’s AI platform to address hard-to-drug targets Collaboration will strengthen Bayer’s research...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Bayer Welcomes Kacy Perry as New Country Division Head for Crop Science Canada

The Crop Science division of Bayer announced that Kacy Perry has been appointed the Country Division Head (CDH) for Crop Science Canada, effective July 1. In this role, she will lead 550+ employees working...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Bayer Completes Acquisition of Perfuse Therapeutics

Bayer today announced the completion of the acquisition of Perfuse Therapeutics, Inc. As a result, Perfuse Therapeutics will now be fully integrated into Bayer. As announced previously ,...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief

Key Facts Campaign: Project DIY is a new campaign under Aleve’s recently launched Feel Aleve ® platform. Project DIY showcases how, when...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions

Key Facts: Bayer’s AMBELVIST ® (gadoquatrane) becomes the lowest-dose macrocyclic gadolinium (Gd)-based contrast agent (mGBCA) approved...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Dr. Jost Reinhard Appointed President of Bayer’s Radiology Business

Bayer today announced that Dr. Jost Reinhard has been appointed President of the Radiology business within Bayer’s Pharmaceuticals Division, effective August 1, 2026. In his new capacity, he will report...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Bayer Announces Global Consumer Health Leadership Changes to Accelerate Growth

Bayer today announced leadership changes within its Consumer Health division to accelerate growth, strengthen commercial execution, and further enhance speed of decision making. These changes reflect the...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)
Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease

Investigational results from FIND-CKD provide full efficacy and safety data and is the fifth consecutive Phase III clinical trial where KERENDIA met its primary endpoint—adding to a clinical trial program...

BAYRY : 15.1850 (+9.64%)
BAYZF : 60.0000 (+8.62%)
BAYN : 0.0100 (unch)

Business Summary

Bayer AG is an international research-based company active in life sciences, polymers, and chemicals. Bayer's operating units include health-care products, material sciences, and crop sciences. Bayer's over-the-counter health-care product division is the third-largest in the world. HealthCare subgroup...

See More

Key Turning Points

3rd Resistance Point 62.4867
2nd Resistance Point 61.9333
1st Resistance Point 60.9667
Last Price 60.0000
1st Support Level 59.4467
2nd Support Level 58.8933
3rd Support Level 57.9267

See More

52-Week High 61.3800
Last Price 60.0000
Fibonacci 61.8% 49.0720
Fibonacci 50% 45.2700
Fibonacci 38.2% 41.4680
52-Week Low 29.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.